04.12.2012 Views

Design of functional dendritic polymers for application as drug and ...

Design of functional dendritic polymers for application as drug and ...

Design of functional dendritic polymers for application as drug and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Sideratou et al: Dendritic <strong>polymers</strong> <strong>for</strong> <strong>application</strong> <strong>as</strong> <strong>drug</strong> <strong>and</strong> gene delivery systems<br />

range <strong>of</strong> the sodium cation present in extracellular fluids,<br />

i.e. 0.142 M, (Guyton <strong>and</strong> Hall, 2000) the betameth<strong>as</strong>one<br />

valerate w<strong>as</strong> rele<strong>as</strong>ed in relatively small quantities. The<br />

gradually rele<strong>as</strong>ed betameth<strong>as</strong>one valerate from the<br />

multi<strong>functional</strong> dendrimer <strong>for</strong>med crystallites in the<br />

aqueous medium <strong>as</strong> determined by light scattering. The<br />

precipitated material w<strong>as</strong> analyzed with 1 H NMR <strong>and</strong> its<br />

spectrum corresponded to that <strong>of</strong> betameth<strong>as</strong>one valerate.<br />

This finding should be considered when PEGylated<br />

dendrimers are used <strong>as</strong> <strong>drug</strong> delivery systems in<br />

experiments in vitro <strong>and</strong> in vivo, since sodium chloride in<br />

extracellular fluids <strong>and</strong> pot<strong>as</strong>sium chloride in intracellular<br />

environment can be complexed with PEG chains (Wang et<br />

al, 2000; Bogan <strong>and</strong> Agnes, 2002) affecting the overall<br />

rele<strong>as</strong>e pr<strong>of</strong>ile <strong>of</strong> the <strong>drug</strong>. Thus, the possibility <strong>of</strong><br />

triggering <strong>drug</strong> rele<strong>as</strong>e in the extracellular fluid, i.e. be<strong>for</strong>e<br />

endocytosis to the target-cells, should be taken into<br />

account when designing a targeted PEGylated <strong>drug</strong><br />

delivery system.<br />

The <strong>drug</strong> delivery effectiveness <strong>of</strong> analogous<br />

multi<strong>functional</strong> dendrimers w<strong>as</strong> modeled by investigating<br />

their interaction with multilamellar liposomes consisting<br />

<strong>of</strong> phosphatidylcholine/cholesterol/dihexadecyl phosphate<br />

(19:9.5:1) <strong>and</strong> dispersed in aqueous or phosphate buffer<br />

solutions (Pantos et al, 2005). The multilamellar liposomes<br />

bear the phosphate moiety <strong>as</strong> recognizable group.<br />

They were used <strong>as</strong> simple models be<strong>for</strong>e one resorts<br />

to the use <strong>of</strong> cells; after all liposomes are considered <strong>as</strong> the<br />

closest analogues to cells. On the other h<strong>and</strong>,<br />

poly(propylene imine) fourth generation dendrimers were<br />

<strong>functional</strong>ized with 6 (DAB-G6 ) or 12 (DAB-G12)<br />

guanidinium groups <strong>as</strong> targeting lig<strong>and</strong>s, while the<br />

remaining toxic, external primary amino groups <strong>of</strong> the<br />

dendrimers were allowed to interact with propylene oxide<br />

af<strong>for</strong>ding the corresponding hydroxylated derivatives. The<br />

scheme <strong>of</strong> the reactions modifying the dendrimeric surface<br />

[BTV] x10 -4 M<br />

1.6<br />

1.4<br />

1.2<br />

1.0<br />

0.8<br />

0.6<br />

0.4<br />

is shown in Figure 15. DAB-G0 dendrimer, which does<br />

not contain any guanidinium group w<strong>as</strong> used <strong>as</strong> a<br />

reference compound. The so-prepared dendrimers were<br />

loaded with corticosteroid <strong>drug</strong>s, i.e. betameth<strong>as</strong>one<br />

dipropionate <strong>and</strong> betameth<strong>as</strong>one valerate <strong>for</strong> investigating<br />

their transfer to liposomes.<br />

Microscopic, ζ-potential, <strong>and</strong> Dynamic Light<br />

Scattering (DLS) techniques have shown that liposomesdendrimers<br />

molecular recognition occurs leading to the<br />

<strong>for</strong>mation <strong>of</strong> large aggregates at dendrimer/dihexadecyl<br />

phosphate molar ratios higher than 1:30, <strong>as</strong> visually<br />

observed with ph<strong>as</strong>e contr<strong>as</strong>t optical microscopy. Calcein<br />

liposomal entrapment experiments demonstrate a limited<br />

leakage, i.e. less than 13%, following liposomes<br />

interaction with the modified dendrimers at 1:25<br />

dendrimer/ dihexadecyl phosphate molar ratio. This<br />

indicates that the membrane <strong>of</strong> the liposomes remains<br />

almost intact during their molecular recognition with these<br />

dendrimers. Isothermal Titration Calorimety (ITC)<br />

indicates that the enthalpy <strong>of</strong> the interaction is dependent<br />

on the number <strong>of</strong> the guanidinium groups present at the<br />

dendrimeric surface. Furthermore, the process is reversible<br />

<strong>and</strong> redispersion <strong>of</strong> the aggregates occurs by adding<br />

concentrated phosphate buffer.<br />

The interaction between these <strong>drug</strong>-loaded<br />

dendrimers <strong>and</strong> multilamellar liposomes results in the<br />

transport <strong>of</strong> <strong>drug</strong>s from the dendrimeric derivatives to the<br />

‘empty’ liposomes <strong>as</strong> summarized in Table 3. The<br />

experiments demonstrate that about 25% <strong>of</strong> BD or BV is<br />

present in the precipitated aggregates when DAB-G0 w<strong>as</strong><br />

used. When the guanidinylated dendrimers DAB-G6 <strong>and</strong><br />

DAB-G12 were used, the amount <strong>of</strong> <strong>drug</strong>s in the<br />

precipitate incre<strong>as</strong>es substantially becoming about 60%<br />

<strong>and</strong> 80%, respectively.<br />

0.2<br />

0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4<br />

[NaCl] / M<br />

Figure 14. Plot <strong>of</strong> the concentration <strong>of</strong> betameth<strong>as</strong>one valerate in a 2.50 x 10 -5 M dendrimeric solution <strong>as</strong> a function <strong>of</strong> added NaCl.<br />

Reproduced from Paleos et al, 2004 with kind permission from American Chemical Society.<br />

80

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!